INDICATION VYKAT XR is indicated for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS). Contraindications Use of VYKAT XR is ...

Positioned as the only approved therapy for PWS-related hyperphagia, VYKAT XR is expected to make a meaningful impact due to its broad patient coverage and robust support via the Soleno One program.